You are here

CAMBRIDGE SCIENTIFIC, INC.

Company Information
Address
CAMBRIDGE SCIENTIFIC, INC. 180 FAWCETT ST
CAMBRIDGE, MA 02138
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. CHILDHOOD IMMUNIZATION FOR DENTAL CARIES

    Amount: $100,000.00

    N/A

    SBIRPhase I1997Department of Health and Human Services
  2. Delivery of Vaccines by Biodegradable Polymeric Microcapsules with Bioadhesion Properties

    Amount: $591,512.00

    The development of vaccines is of prime inportance to issues of public health and to issues of military significance. Oral vaccines present a means of delivery which is both convenient to the patient ...

    SBIRPhase II1996Department of Defense Army
  3. Stable Biodegradable Polymers for Delivery of Both Polar and Non-Polar Drugs

    Amount: $70,000.00

    N/A

    SBIRPhase I1996Department of Defense Army
  4. INJECTABLE RESORBABLE BONE CEMENT

    Amount: $100,000.00

    N/A

    SBIRPhase I1996Department of Health and Human Services
  5. RESORBABLE BUFFERED INTERNAL FIXATION DEVICES

    Amount: $100,000.00

    N/A

    SBIRPhase I1996Department of Health and Human Services
  6. SBIR Phase I: Ferroelectric Biopolymers

    Amount: $75,000.00

    N/A

    SBIRPhase I1996National Science Foundation
  7. ANTIRETROVIAL DNA VACCINE

    Amount: $100,000.00

    N/A

    SBIRPhase I1996Department of Health and Human Services
  8. MICROGRAVITY PROCESSING OF BIOPOLYMER/METAL COMPOSITES FOR NLO APPLICATIONS

    Amount: $70,000.00

    N/A

    SBIRPhase I1996National Aeronautics and Space Administration
  9. Delivery of Vaccines by Biodegradable Polymeric Microcapsules with Bioadhesion Properties

    Amount: $70,000.00

    N/A

    SBIRPhase I1995Department of Defense Army
  10. Biodegradable, Controlled Release of Modern Progestins

    Amount: $62,896.00

    In spite of the availability of several newly approved progestins, which could achieve successas modern low-dose oral contraceptives (OC), problems in OC use remain. One consideration inachieving succ ...

    SBIRPhase I1994Department of Health and Human Services
US Flag An Official Website of the United States Government